Enhanced Recovery After Spine Surgery Randomized Clinical Trial
NCT ID: NCT05830331
Last Updated: 2023-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
284 participants
INTERVENTIONAL
2019-02-18
2021-10-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced Recovery After Spine Surgery
NCT02949518
Complex Spine Enhanced Recovery After Surgery (ERAS)
NCT04538092
ERAS Protocol for Single-level Posterior Lumbar Arthrodesisprospective Study.
NCT05022745
Enhanced Recovery After Surgery in Oblique Lumbar Interbody Fusion
NCT05959343
Sngception and Pain in Spine Enhanced Recovery After Surgery (ERAS) Pathways
NCT05885802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
No interventions assigned to this group
Treatment
ERASS Pathway
Enhanced Recovery After Spinal Surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ERASS Pathway
Enhanced Recovery After Spinal Surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Incarceration
* Patients under the age of 18
* Patients unable to participate in the consent procedure
* Patients undergoing emergent surgery
* Patients with liver disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zarina Ali
Chief, Penn Presbyterian Medical Center Department of Neurosurgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zarina Ali, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Neil Malhotra, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
831303
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.